Viatris Inc. (VTRS)
NASDAQ: VTRS · IEX Real-Time Price · USD
11.84
+0.07 (0.59%)
At close: Jul 19, 2024, 4:00 PM
11.80
-0.04 (-0.34%)
Pre-market: Jul 22, 2024, 7:01 AM EDT

Viatris Market Cap

Viatris has a market cap or net worth of $14.10 billion as of July 22, 2024. Its market cap has increased by 19.49% in one year.

Market Cap
14.10B
Enterprise Value
31.05B
1-Year Change
19.49%
Ranking
Category
Stock Price
$11.84

Market Cap Chart

Since December 1, 1998, Viatris's market cap has increased from $4.38B to $14.10B, an increase of 221.80%. That is a compound annual growth rate of 4.66%.

History

DateMarket Cap% Change
Jul 19, 202414.10B8.51%
Dec 29, 202312.99B-3.74%
Dec 30, 202213.50B-17.51%
Dec 31, 202116.36B61.24%
Dec 31, 202010.15B-2.18%
Dec 31, 201910.37B-26.57%
Dec 31, 201814.13B-37.75%
Dec 29, 201722.70B11.18%
Dec 30, 201620.41B-23.22%
Dec 31, 201526.59B26.03%
Dec 31, 201421.10B26.97%
Dec 31, 201316.62B48.53%
Dec 31, 201211.19B22.22%
Dec 30, 20119.15B39.85%
Dec 31, 20106.54B16.21%
Dec 31, 20095.63B86.89%
Dec 31, 20083.01B-13.89%
Dec 31, 20073.50B-17.30%
Dec 29, 20064.23B-1.54%
Dec 30, 20054.30B-9.67%
Dec 31, 20044.76B-29.94%
Dec 31, 20036.79B58.86%
Dec 31, 20024.27B-9.23%
Dec 31, 20014.71B49.79%
Dec 29, 20003.14B-3.42%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Quest Diagnostics 16.22B
BioMarin Pharmaceutical 15.97B
Incyte 14.81B
Neurocrine Biosciences 14.66B
United Therapeutics 14.60B
Sarepta Therapeutics 13.76B
Insulet 13.66B
Revvity 13.34B
Market Cap Rankings